Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Pfeiffer syndrome type 3 (PS3) is a severe type of Pfeiffer syndrome (PS), characterized by bicoronal craniosynostosis, severe associated functional disorders, and hand, foot and elbow abnormalities.
Biomarker and diagnostic research for Pfeiffer syndrome type 3 has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for Pfeiffer syndrome type 3.
3 publications have been identified in PubMed for Pfeiffer syndrome type 3. Research spans Case Report / Case Series (67%) and Diagnostic / Biomarker (33%).
Bertucci E (2026). [PMID: 40879620](https://pubmed.ncbi.nlm.nih.gov/40879620/). *International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics*. [Case Report / Case Series]
Yuan Y (2025). [PMID: 40668396](https://pubmed.ncbi.nlm.nih.gov/40668396/). *Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery*. [Diagnostic / Biomarker]
Inoue E (2024). [PMID: 39503147](https://pubmed.ncbi.nlm.nih.gov/39503147/). *Anesthesia progress*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:40 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Pfeiffer syndrome type 3